The estimated Net Worth of Bernard J Zovighian is at least $7.7 millió dollars as of 30 May 2024. Bernard Zovighian owns over 8,617 units of Edwards Lifesciences Corp stock worth over $4,655,810 and over the last 9 years Bernard sold EW stock worth over $3,043,062.
Bernard has made over 9 trades of the Edwards Lifesciences Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Bernard sold 8,617 units of EW stock worth $755,539 on 30 May 2024.
The largest trade Bernard's ever made was exercising 20,000 units of Edwards Lifesciences Corp stock on 27 April 2017 worth over $1,337,200. On average, Bernard trades about 3,451 units every 118 days since 2016. As of 30 May 2024 Bernard still owns at least 68,217 units of Edwards Lifesciences Corp stock.
You can see the complete history of Bernard Zovighian stock trades at the bottom of the page.
Bernard's mailing address filed with the SEC is ONE EDWARDS WAY, , IRVINE, CA, 92614.
Over the last 22 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo és Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: